Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality

被引:931
作者
Dobnig, Harald [1 ]
Pilz, Stefan [3 ]
Scharnagl, Hubert [2 ]
Renner, Wilfried [2 ]
Seelhorst, Ursula [4 ]
Wellnitz, Britta [4 ]
Kinkeldei, Jurgen [5 ]
Boehm, Bernhard O. [6 ]
Weihrauch, Gisela [2 ]
Maerz, Winfried [2 ,7 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Endocrinol & Nucl Med, A-8036 Graz, Austria
[2] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria
[3] Heidelberg Univ, Mannheim Med Fac, Dept Publ Hlth Social & Prevent Med, Heidelberg, Germany
[4] LURIC Study Nonprofit LLC, Freiburg, Germany
[5] Synlab Ctr Lab Diagnost Stuttgart, Leinfelden Echterdingen, Germany
[6] Univ Ulm, Dept Internal Med, Div Endocrinol & Diabet, D-7900 Ulm, Germany
[7] Synlab Ctr Lab Diagnost Heidelberg, Eppelheim, Germany
关键词
D O I
10.1001/archinte.168.12.1340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In cross-sectional studies, low serum levels of 25-hydroxyvitamin D are associated with higher prevalence of cardiovascular risk factors and disease. This study aimed to determine whether endogenous 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels are related to all-cause and cardiovascular mortality. Methods: Prospective cohort study of 3258 consecutive male and female patients (mean [SD] age, 62 [10] years) scheduled for coronary angiography at a single tertiary center. We formed quartiles according to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels within each month of blood drawings. The main outcome measures were all-cause and cardiovascular deaths. Results: During a median follow-up period of 7.7 years, 737 patients (22.6%) died, including 463 deaths from cardiovascular causes. Multivariate-adjusted hazard ratios (HRs) for patients in the lower two 25-hydroxyvitamin D quartiles (median, 7.6 and 13.3 ng/mL [to convert 25-hydroxyvitamin D levels to nano-moles per liter, multiply by 2.496]) were higher for all-cause mortality (HR, 2.08; 95% confidence interval [CI], 1.60-2.70; and HR, 1.53; 95% CI, 1.17-2.01; respectively) and for cardiovascular mortality (HR, 2.22; 95% CI, 1.57-3.13; and HR, 1.82; 95% CI, 1.29-2.58; respectively) compared with patients in the highest 25-hydroxyvitamin D quartile (median, 28.4 ng/mL). Similar results were obtained for patients in the lowest 1,25-dihydroxyvitamin D quartile. These effects were independent of coronary artery disease, physical activity level, Charlson Comorbidity Index, variables of mineral metabolism, and New York Heart Association functional class. Low 25-hydroxyvitamin D levels were significantly correlated with variables of inflammation (C-reactive protein and interleukin 6 levels), oxidative burden (serum phospholipid and glutathione levels), and cell adhesion (vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 levels). Conclusions: Low 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels are independently associated with all-cause and cardiovascular mortality. A causal relationship has yet to be proved by intervention trials using vitamin D.
引用
收藏
页码:1340 / 1349
页数:10
相关论文
共 37 条
[1]   High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in Northern Italy for initial screening [J].
Bettica, P ;
Bevilacqua, M ;
Vago, T ;
Norbiato, G .
OSTEOPOROSIS INTERNATIONAL, 1999, 9 (03) :226-229
[2]   Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis [J].
Bischoff-Ferrari, HA ;
Zhang, YQ ;
Kiel, DP ;
Felson, DT .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :821-826
[3]  
Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752
[4]   Effect of vitamin D on falls - A meta-analysis [J].
Bischoff-Ferrari, HA ;
Dawson-Hughes, B ;
Willett, WC ;
Staehelin, HB ;
Bazemore, MG ;
Zee, RY ;
Wong, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16) :1999-2006
[5]   Fracture prevention with vitamin D supplementation - A meta-analysis of randomized controlled trials [J].
Bischoff-Ferrari, HA ;
Willett, WC ;
Wong, JB ;
Giovannucci, E ;
Dietrich, T ;
Dawson-Hughes, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (18) :2257-2264
[6]   Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [J].
Bischoff-Ferrari, Heike A. ;
Giovannucci, Edward ;
Willett, Walter C. ;
Dietrich, Thomas ;
Dawson-Hughes, Bess .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :18-28
[7]   Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter [J].
Chapuy, MC ;
Schott, AM ;
Garnero, P ;
Hans, D ;
Delmas, PD ;
Meunier, PJ ;
Breart, G ;
Dargent, P ;
Haussher, E ;
Cormier, C ;
Sebert, JL ;
Favier, F ;
Marcelli, C ;
Grandjean, H ;
Ribot, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1129-1133
[8]  
Chiu KC, 2004, AM J CLIN NUTR, V79, P820
[9]   25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey [J].
Chonchol, M. ;
Scragg, R. .
KIDNEY INTERNATIONAL, 2007, 71 (02) :134-139
[10]   How to measure comorbidity: a critical review of available methods [J].
de Groot, V ;
Beckerman, H ;
Lankhorst, GJ ;
Bouter, LM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (03) :221-229